Company intelligence / Profile preview

LEAPChem

Hangzhou, Zhejiang, Chinaleapchem.com ↗

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

LEAPChem supplies nearly 200,000 rare and innovative chemical products including pharmaceutical intermediates, APIs, peptides/proteins, fine chemicals for research and bulk manufacturing. The company does not develop its own clinical-stage therapeutics but supports the life sciences industry with custom synthesis services and contract development/manufacturing.

Modalities: Small moleculePeptidesProtein (including protein and peptide reagents)APIs (Active Pharmaceutical Ingredients)Biologic (limited to research chemicals and intermediates)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on LEAPChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LEAPChem.

Explore the full profile